{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:06:27Z","timestamp":1790996787629,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s12325-009-0062-1","type":"journal-article","created":{"date-parts":[[2009,9,14]],"date-time":"2009-09-14T18:38:27Z","timestamp":1252953507000},"page":"776-783","source":"Crossref","is-referenced-by-count":58,"title":["A combination povidone-iodine 0.4%\/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis"],"prefix":"10.1007","volume":"26","author":[{"given":"J. S.","family":"Pelletier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Trattler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. C.","family":"Ritterband","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Braverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M.","family":"Samson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Capriotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,7]]},"reference":[{"key":"62_CR1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/oxfordjournals.epirev.a036304","volume":"9","author":"E. Ford","year":"1987","unstructured":"Ford E, Nelson KE, Warren D. Epidemiology of epidemic keratoconjunctivitis. Epidemiol Rev. 1987;9:244\u2013261.","journal-title":"Epidemiol Rev"},{"key":"62_CR2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0161-6420(02)00992-2","volume":"109","author":"J. Hillenkamp","year":"2002","unstructured":"Hillenkamp J, Reinhard T, Ross R, et al. The effects of cidofovir 1% with and without cyclosporin A 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology. 2002;109:845\u2013850.","journal-title":"Ophthalmology"},{"key":"62_CR3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/jop.2005.21.157","volume":"21","author":"B. Teuchner","year":"2005","unstructured":"Teuchner B, Nagl M, Schidlbauer A, et al. Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis - a double-blind, randomized, phase-2 clinical trial. J Ocul Pharmacol Ther. 2005;21:157\u2013164.","journal-title":"J Ocul Pharmacol Ther"},{"key":"62_CR4","first-page":"460","volume":"41","author":"E.G. Romanowski","year":"2000","unstructured":"Romanowski EG, Gordon YJ. Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model. Invest Ophthalmol Vis Sci. 2000;41:460\u2013463.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"62_CR5","unstructured":"Clinicaltrials.gov web site. An evaluation of the efficacy and safety of AL-46383A ophthalmic solution for the treatment of adenoviral conjunctivitis. Identifier: NCT00901693. Available at: http:\/\/clinicaltrials.gov\/ct2\/results?term=NCT00901693 . Accessed August 2009."},{"key":"62_CR6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archopht.1996.01100130573014","volume":"114","author":"E.G. Romanowski","year":"1996","unstructured":"Romanowski EG, Roba LA, Wiley L, Araullo-Cruz T, Gordon YJ. The effects of corticosteroids on adenoviral replication. Arch Ophthalmol. 1996;114:581\u2013585.","journal-title":"Arch Ophthalmol"},{"key":"62_CR7","unstructured":"Bhagwat D, Oshlack B. Stabilized PVP-I solutions. United States Patent 5126127. June 30, 1992. Available at: www.freepatentsonline.com\/5126127.html ."},{"key":"62_CR8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/JCM.15.4.635-639.1982","volume":"15","author":"R. Berkelman","year":"1982","unstructured":"Berkelman R, Holland B, Anderson R. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol. 1982;15:635\u2013639.","journal-title":"J Clin Microbiol"},{"key":"62_CR9","first-page":"54","volume":"30","author":"E. Hale","year":"1969","unstructured":"Hale E. The treatment of corneal ulcer with povidone-iodine (Betadine). N C Med J. 1969;30:54\u201356.","journal-title":"N C Med J"},{"key":"62_CR10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0002-9394(02)01701-4","volume":"134","author":"S.J. Isenberg","year":"2002","unstructured":"Isenberg SJ, Apt L, Valenton M, et al. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children. Am J Ophthalmol. 2002;134:681\u2013688.","journal-title":"Am J Ophthalmol"},{"issue":"suppl.A","key":"62_CR11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0195-6701(85)80064-5","volume":"6","author":"G. Schuhman","year":"1985","unstructured":"Schuhman G, Vidic B. Clinical experience with povidone-iodine eyedrops in conjunctivitis and keratoconjunctivitis. J Hosp Infect. 1985;6(suppl. A):173\u2013175.","journal-title":"J Hosp Infect"},{"key":"62_CR12","first-page":"323","volume":"50","author":"J. Pernicky","year":"1994","unstructured":"Pernicky J. Our experience with the use of povidone-iodine drops in the treatment of viral conjunctivitis [article in Czech]. Czechoslovenska Oftalmologie. 1994;50:323\u2013325.","journal-title":"Czechoslovenska Oftalmologie"},{"key":"62_CR13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0161-6420(89)32897-1","volume":"96","author":"L. Apt","year":"1989","unstructured":"Apt L, Isenberg SJ, Yoshimori R, Spierer A. Outpatient topical use of povidone-iodine in preparing the eye for surgery. Ophthalmology. 1989;96:289\u2013292.","journal-title":"Ophthalmology"},{"key":"62_CR14","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0161-6420(91)32052-9","volume":"98","author":"M.G. Speaker","year":"1991","unstructured":"Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98:1769\u20131775.","journal-title":"Ophthalmology"},{"key":"62_CR15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0002-9394(14)71640-X","volume":"124","author":"S.J. Isenberg","year":"1997","unstructured":"Isenberg SJ, Apt L, Yoshimori R, Pham CB, Lam NK. Efficacy of topical povidone-iodine during the first week after ophthalmic surgery. Am J Ophthalmol. 1997;124:31\u201335.","journal-title":"Am J Ophthalmol"},{"key":"62_CR16","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJM199503023320903","volume":"332","author":"S.J. Isenberg","year":"1995","unstructured":"Isenberg SJ, Apt L, Wood M. A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum. N Engl J Med. 1995;332:562\u2013566.","journal-title":"N Engl J Med"},{"key":"62_CR17","first-page":"341","volume":"30","author":"R. Abel","year":"1998","unstructured":"Abel R, Abel AD. Use of povidone-iodine in the treatment of presumptive adenoviral conjunctivitis. Ann Ophthalmol. 1998;30:341\u2013343.","journal-title":"Ann Ophthalmol"},{"key":"62_CR18","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0161-6420(02)01176-4","volume":"109","author":"O. Weijtens","year":"2002","unstructured":"Weijtens O, Schoemaker R, Romijn F, et al. Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate. Ophthalmology. 2002;109:1187\u20131191.","journal-title":"Ophthalmology"},{"key":"62_CR19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/bjo.2008.154906","volume":"93","author":"M. Awan","year":"2009","unstructured":"Awan M, Agarwal P, Watson D, et al. Penetration of topical and subconjunctival corticosteroids in human aqueous humor and its therapeutic significance. Br J Ophthalmol. 2009;93:708\u2013713.","journal-title":"Br J Ophthalmol"},{"key":"62_CR20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/ICO.0b013e31815873c7","volume":"27","author":"E.J. Holland","year":"2008","unstructured":"Holland EJ, Bartlett JD, Paterno MR, et al. Effects on loteprednol\/tobramycin versus dexamethasone\/tobramycin on intraocular pressure in healthy volunteers. Cornea. 2008;27:50\u201355.","journal-title":"Cornea"},{"key":"62_CR21","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0886-3350(01)00863-X","volume":"27","author":"N. Mohan","year":"2001","unstructured":"Mohan N, Gupta V, Tandon R, et al. Topical ciprofloxacin-dexamethasone combination therapy after cataract surgery randomized controlled clinical trial. J Cataract Refract Surg. 2001;27:1975\u20131978.","journal-title":"J Cataract Refract Surg"},{"key":"62_CR22","unstructured":"Samson CM, Capriotti JA, Liang B. Ophthalmic compositions comprising povidone-iodine. United States Patent Application 20070219170. September 20, 2007. Available at: www.freepatentsonline.com\/y2007\/0219170.html ."},{"key":"62_CR23","first-page":"773","volume-title":"Cornea and External Disease: Clinical Diagnosis and Management","author":"J. Krachmer","year":"1997","unstructured":"Krachmer J, Mannis M, Holland E. Cornea and External Disease: Clinical Diagnosis and Management. St. Louis: Mosby; 1997:773\u2013775."},{"key":"62_CR24","first-page":"359","volume-title":"The Cornea: Scientific Foundations and Clinical Practice","author":"G. Smolin","year":"2004","unstructured":"Smolin G, Thoft R. The Cornea: Scientific Foundations and Clinical Practice. Fourth Edition. New York: Lippincott Williams & Wilkins; 2004:359\u2013364.","edition":"Fourth Edition"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-009-0062-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-009-0062-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-009-0062-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T05:17:15Z","timestamp":1590124635000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-009-0062-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["62"],"URL":"https:\/\/doi.org\/10.1007\/s12325-009-0062-1","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}